PRMT5 controls the innate immune response
<p>Protein arginine methyltransferase 5 (PRMT5) is a symmetric di-methyltransferase frequently overexpressed in various cancers, including colorectal cancer. It is known that PRMT5-mediated methylation of E2 promoter binding factor 1 (E2F1) not only supports cancer cell growth but also influen...
Egile nagusia: | Zhang, C |
---|---|
Beste egile batzuk: | La Thangue, N |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
2024
|
Antzeko izenburuak
-
The methyltransferases PRMT4/CARM1 and PRMT5 control differentially myogenesis in zebrafish.
nork: Julie Batut, et al.
Argitaratua: (2011-01-01) -
Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation
nork: Parisa Dashti, et al.
Argitaratua: (2023-12-01) -
Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5
nork: Melody D. Fulton, et al.
Argitaratua: (2022-01-01) -
Pan-cancer analysis identifies protein arginine methyltransferases PRMT1 and PRMT5 and their related signatures as markers associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma
nork: Jia Wang, et al.
Argitaratua: (2023-12-01) -
Understanding the role of PRMT5 in neuroblastoma
nork: Albayrak, G
Argitaratua: (2023)